What two new studies found about the delta variant, Novavax's Covid-19 vaccine is 90% effective, and more.

Novavax's Covid-19 vaccine is 90% effective—but the company isn't seeking FDA authorization yet (Monday, June 14)

The Covid-19 vaccine developed by Novavax showed an overall efficacy of 90.4% against symptomatic cases of the disease, according to Phase 3 trial results—but the company said it won't immediately seek FDA authorization in the United States.

Just how dangerous is the delta variant? Here's what 2 new studies found. (Tuesday, June 15)

The delta coronavirus variant is significantly likelier to lead to hospitalization than even the dangerous alpha variant, according to two new studies—evidence that arrived as the United Kingdom announced plans to delay its reopening due to the delta variant's spread.

U.S. News names the 'Best Children's Hospitals' of 2021 (Wednesday, June 16)

U.S. News & World Report on Tuesday released its "Best Children's Hospitals" rankings for 2021, naming the 10 best children's hospitals in the country as well as the top 50 children's hospitals in each of 10 pediatric specialties.

Should you mandate a Covid-19 vaccine for your staff? Ask these 5 questions first. (Thursday, June 17)

Across the country, health care employers are facing a pressing question: How do you increase the number of staff vaccinated against Covid-19? Advisory Board's Miriam Sznycer-Taub, Lauren Woodrow, and Heather Bell spoke with Kimberly Daniel, partner at the health care law firm Hancock, Daniel & Johnson, P.C about the implications of mandating Covid-19 vaccines for your employees.